U.S. Physical Therapy (USPH) Stock Price, News & Analysis

Company Overview

U.S. Physical Therapy, Inc. is a healthcare services company that operates outpatient physical therapy clinics throughout the United States. The company provides rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength or physical function.

In addition to operating clinics, U.S. Physical Therapy develops partnerships with physical therapists and physician groups through management arrangements. The company provides administrative and business support, including billing, information systems, human resources, marketing and compliance services, while clinical care is delivered by licensed healthcare professionals.

The company also provides industrial injury prevention and rehabilitation services to employers and their workforces. These services may include workplace assessments, injury prevention programs, ergonomic consulting and related services designed to help reduce occupational injuries and support employee recovery. U.S. Physical Therapy was founded in 1990 and is headquartered in Houston, Texas. The company serves communities across multiple states and is led by President and Chief Executive Officer Christopher J. Reading.

Key Stats

• Today's Range: $82.55 to $84.69
• 50-Day Range: $75.96 to $86.52
• 52-Week Range: $58.19 to $93.50
• Volume: 235,744 shs
• Average Volume: 177,746 shs
• Market Capitalization: $1.25 billion
• P/E Ratio: 493.20
• Dividend Yield: 2.19%
• Price Target: $98.25
• Consensus Rating: Moderate Buy

U.S. Physical Therapy Stock Analysis - MarketRank™

U.S. Physical Therapy scored higher than 77% of companies evaluated by MarketBeat, and ranked 117th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

U.S. Physical Therapy has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 1 strong buy rating, 4 buy ratings, 2 hold ratings, and no sell ratings.

Upside Potential

U.S. Physical Therapy has a consensus price target of $98.25, representing about 17.2% upside from its current price of $83.84.

Amount of Analyst Coverage

U.S. Physical Therapy has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 18.34%

Earnings Growth

Earnings for U.S. Physical Therapy are expected to grow by 18.34% in the coming year, from $2.89 to $3.42 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of U.S. Physical Therapy is 493.20, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.66.

Price to Earnings Ratio vs. Sector

The P/E ratio of U.S. Physical Therapy is 493.20, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.00.

Price to Earnings Growth Ratio

U.S. Physical Therapy has a PEG Ratio of 2.13. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

U.S. Physical Therapy has a P/B Ratio of 2.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

8.88% of the float of U.S. Physical Therapy has been sold short.

Short Interest Ratio / Days to Cover

U.S. Physical Therapy has a short interest ratio ("days to cover") of 8.12.

Change versus previous month

Short interest in U.S. Physical Therapy has recently increased by 0.71%, indicating that investor sentiment is decreasing.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

U.S. Physical Therapy pays a meaningful dividend of 2.20%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

U.S. Physical Therapy has been increasing its dividend for 6 years.

Dividend Coverage

The dividend payout ratio of U.S. Physical Therapy is 1,082.35%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 53.80% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.66

News Sentiment

U.S. Physical Therapy has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for U.S. Physical Therapy this week, compared to 3 articles on an average week.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, U.S. Physical Therapy insiders have bought more of their company's stock than they have sold. Specifically, they have bought $395.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

2.40% of the stock of U.S. Physical Therapy is held by insiders.

Percentage Held by Institutions

U.S. Physical Therapy has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/06/2026
• Record date for 9/11 Dividend: 8/21/2026
• Ex-Dividend for 9/11 Dividend: 8/21/2026
• Dividend Payable: 9/11/2026
• Today: 10/04/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Facilities
• Current Symbol: NYSE:USPH
• CIK: 885978
• Web: www.usph.com
• Phone: (713) 297-7000
• Fax: 713-297-7090
• Employees: 7,294
• Year Founded: 1990

Price Target and Rating

• Average Price Target for U.S. Physical Therapy: $98.25
• High Price Target: $102.00
• Low Price Target: $95.00
• Potential Upside/Downside: +17.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.86
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.17
• Trailing P/E Ratio: 493.20
• Forward P/E Ratio: 29.01
• P/E Growth: 2.13
• Net Income: $39.58 million
• Net Margins: 3.97%
• Pretax Margin: 8.30%
• Return on Equity: 9.39%
• Return on Assets: 3.65%

Debt

• Debt-to-Equity Ratio: 0.48
• Current Ratio: 1.27
• Quick Ratio: 1.27

Sales & Book Value

• Annual Sales: $780.99 million
• Price / Sales: 1.60
• Cash Flow: $4.13 per share
• Price / Cash Flow: 20.28
• Book Value: $31.37 per share
• Price / Book: 2.67

Miscellaneous

• Outstanding Shares: 14,920,000
• Free Float: 14,565,000
• Market Cap: $1.25 billion
• Optionable: Optionable
• Beta: 1.12